Reconova closes Series B+ at CNY500M post-money
Reconova completed its Series B+ financing at an issuer-disclosed CNY500M post-money valuation. The filing lists CNY35000000 of primary consideration among the disclosed retained investors.
Evidence notes
- Issuer prospectus states pre-money valuation of CNY465000000 and post-money valuation of CNY500000000.
- Primary consideration treatment: CNY35M Intel primary cash subscription; Su Xiaosheng's later non-cash contribution of Beijing Deep Sense equity is excluded from the cash financing amount.
- Investors: Intel Asia Pacific Research and Development